Lack of cross-tolerance to the antinociceptive effects of systemic and topical cannabinoids in morphine-tolerant mice
- 23 November 2004
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 371 (2-3), 122-127
- https://doi.org/10.1016/j.neulet.2004.08.052
Abstract
Opioids and cannabinoids produce antinociception through activity at spinal, supraspinal and peripheral sites. Tolerance to the antinociceptive effects of both the opioids and the cannabinoids develop when these agents are administered chronically. Although mutual potentiation of antinociceptive effects have been reported between opioids and cannabinoids, the development of antinociceptive cross-tolerance between these systems has not been demonstrated consistently. In the present investigation, we explored the possibility of antinociceptive cross-tolerance between systemic or topical morphine and systemic or topical cannabinoids in mice. Mice were made tolerant to morphine either by the subcutaneous (s.c.) implantation of a morphine pellet or repeated topical administration and then challenged with the mixed CB1 and CB2 receptor agonist WIN55, 212-2 given s.c. or topically. Antinociception was indicated by increased tail-flick latencies to noxious radiant heat. Implantation with morphine pellets did not attenuate the antinociceptive potency of systemic or topical WIN 55,212-2. Moreover, twice-daily topical administration of morphine did not attenuate the antinociceptive potency of WIN 55,212-2 applied topically. These observations suggest that opioids and cannabinoids produce antinociception through mechanisms that are independent of each other at either the systemic or peripheral levels.Keywords
This publication has 36 references indexed in Scilit:
- Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effectNeuroscience Letters, 2004
- Topical cannabinoid antinociception: synergy with spinal sitesPain, 2003
- Modulation of Oral Morphine Antinociceptive Tolerance and Naloxone-Precipitated Withdrawal Signs by Oral Δ9-TetrahydrocannabinolJournal of Pharmacology and Experimental Therapeutics, 2003
- ‘Knock-down’ of spinal CB1 receptors produces abnormal pain and elevates spinal dynorphin content in micePain, 2002
- The role of T-type calcium channels in morphine analgesia, development of antinociceptive tolerance and dependence to morphine, and morphine abstinence syndromeLife Sciences, 2002
- Importance of sex and relative efficacy at the µ opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioidsPsychopharmacology, 2001
- Effects of neomycin on the development of tolerance to morphine antinociceptionLife Sciences, 2001
- The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic painPain, 2001
- Control of pain initiation by endogenous cannabinoidsNature, 1998
- An Assessment of the Role of Opioid Receptors in the Response to Cannabimimetic DrugsJournal of Neurochemistry, 1986